Novavax gets Japan nod for its COVID-19 vaccine, triggers Takeda payment
2025-09-04 09:03:11 ET
More on Novavax
- Novavax, Inc. (NVAX) Q2 2025 Earnings Call Transcript
- Despite Revenue Jump, Novavax Appears Immune To Long-Term Growth
- Novavax: New Vaccine, Same Old Story - Still A Sell
- Pfizer, Moderna, Novavax respond to Trump’s criticism of COVID shot success
- Florida to eliminate all state vaccine mandates, surgeon general says
Read the full article on Seeking Alpha
For further details see:
Novavax gets Japan nod for its COVID-19 vaccine, triggers Takeda paymentNASDAQ: TKPHF
TKPHF Trading
0.0% G/L:
$37.83 Last:
113 Volume:
$37.83 Open:



